Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Downregulation of cav-1 in prostate cancer cell line PC-3 or human umbilical vein endothelial cells (HUVECs) through cav-1 siRNA significantly reduced basal and VEGF-stimulated phosphorylation of VEGFR2 (Y951), PLCgamma1 (Y783) and/or Akt (S473 & T308) relative to those in control siRNA treated cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP629680.RADAah7s-dWCpf5m4ElWZWmbAKnA9AooVxUvssG-G65OY130_assertion description "[Downregulation of cav-1 in prostate cancer cell line PC-3 or human umbilical vein endothelial cells (HUVECs) through cav-1 siRNA significantly reduced basal and VEGF-stimulated phosphorylation of VEGFR2 (Y951), PLCgamma1 (Y783) and/or Akt (S473 & T308) relative to those in control siRNA treated cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP629680.RADAah7s-dWCpf5m4ElWZWmbAKnA9AooVxUvssG-G65OY130_provenance.
• NP629687.RAD1T0NQkxsGweE1mKQ52hc-msMZtgkQLIciXQCQVwT6M130_assertion description "[Downregulation of cav-1 in prostate cancer cell line PC-3 or human umbilical vein endothelial cells (HUVECs) through cav-1 siRNA significantly reduced basal and VEGF-stimulated phosphorylation of VEGFR2 (Y951), PLCgamma1 (Y783) and/or Akt (S473 & T308) relative to those in control siRNA treated cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP629687.RAD1T0NQkxsGweE1mKQ52hc-msMZtgkQLIciXQCQVwT6M130_provenance.
• NP523931.RA0EmeFiGOqePjUYTbxhBGediDV9HY1dWC8HgIyvC0k5Y130_assertion description "[Downregulation of cav-1 in prostate cancer cell line PC-3 or human umbilical vein endothelial cells (HUVECs) through cav-1 siRNA significantly reduced basal and VEGF-stimulated phosphorylation of VEGFR2 (Y951), PLCgamma1 (Y783) and/or Akt (S473 & T308) relative to those in control siRNA treated cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP523931.RA0EmeFiGOqePjUYTbxhBGediDV9HY1dWC8HgIyvC0k5Y130_provenance.
• NP523903.RAe4egWJLFi3dgNCCi4K2UNP9aM3qSn0Tr1CS05JR5ynU130_assertion description "[Downregulation of cav-1 in prostate cancer cell line PC-3 or human umbilical vein endothelial cells (HUVECs) through cav-1 siRNA significantly reduced basal and VEGF-stimulated phosphorylation of VEGFR2 (Y951), PLCgamma1 (Y783) and/or Akt (S473 & T308) relative to those in control siRNA treated cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP523903.RAe4egWJLFi3dgNCCi4K2UNP9aM3qSn0Tr1CS05JR5ynU130_provenance.
• NP776631.RA9Lpb5pLSSK8rLFpTOHZejVcqqtL4zMtMBqiUNJFiiiM130_assertion description "[Downregulation of cav-1 in prostate cancer cell line PC-3 or human umbilical vein endothelial cells (HUVECs) through cav-1 siRNA significantly reduced basal and VEGF-stimulated phosphorylation of VEGFR2 (Y951), PLCgamma1 (Y783) and/or Akt (S473 & T308) relative to those in control siRNA treated cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP776631.RA9Lpb5pLSSK8rLFpTOHZejVcqqtL4zMtMBqiUNJFiiiM130_provenance.
• NP776636.RAyovm1j_-xLA27nhmVrsQVMiYLZZL74CfzHqmpkUoEK8130_assertion description "[Downregulation of cav-1 in prostate cancer cell line PC-3 or human umbilical vein endothelial cells (HUVECs) through cav-1 siRNA significantly reduced basal and VEGF-stimulated phosphorylation of VEGFR2 (Y951), PLCgamma1 (Y783) and/or Akt (S473 & T308) relative to those in control siRNA treated cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP776636.RAyovm1j_-xLA27nhmVrsQVMiYLZZL74CfzHqmpkUoEK8130_provenance.
• NP776630.RAW3Y1hpSPg9ToguFEhTMKOF50pUcOG788UZ_Rmt7OaNY130_assertion description "[Downregulation of cav-1 in prostate cancer cell line PC-3 or human umbilical vein endothelial cells (HUVECs) through cav-1 siRNA significantly reduced basal and VEGF-stimulated phosphorylation of VEGFR2 (Y951), PLCgamma1 (Y783) and/or Akt (S473 & T308) relative to those in control siRNA treated cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP776630.RAW3Y1hpSPg9ToguFEhTMKOF50pUcOG788UZ_Rmt7OaNY130_provenance.
• NP776633.RAfipl6lVsp2TWhLP3Ub8oFWxH1RJneH1NkzhAYfr5mUM130_assertion description "[Downregulation of cav-1 in prostate cancer cell line PC-3 or human umbilical vein endothelial cells (HUVECs) through cav-1 siRNA significantly reduced basal and VEGF-stimulated phosphorylation of VEGFR2 (Y951), PLCgamma1 (Y783) and/or Akt (S473 & T308) relative to those in control siRNA treated cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP776633.RAfipl6lVsp2TWhLP3Ub8oFWxH1RJneH1NkzhAYfr5mUM130_provenance.
• assertion description "[Downregulation of cav-1 in prostate cancer cell line PC-3 or human umbilical vein endothelial cells (HUVECs) through cav-1 siRNA significantly reduced basal and VEGF-stimulated phosphorylation of VEGFR2 (Y951), PLCgamma1 (Y783) and/or Akt (S473 & T308) relative to those in control siRNA treated cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Downregulation of cav-1 in prostate cancer cell line PC-3 or human umbilical vein endothelial cells (HUVECs) through cav-1 siRNA significantly reduced basal and VEGF-stimulated phosphorylation of VEGFR2 (Y951), PLCgamma1 (Y783) and/or Akt (S473 & T308) relative to those in control siRNA treated cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Downregulation of cav-1 in prostate cancer cell line PC-3 or human umbilical vein endothelial cells (HUVECs) through cav-1 siRNA significantly reduced basal and VEGF-stimulated phosphorylation of VEGFR2 (Y951), PLCgamma1 (Y783) and/or Akt (S473 & T308) relative to those in control siRNA treated cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Downregulation of cav-1 in prostate cancer cell line PC-3 or human umbilical vein endothelial cells (HUVECs) through cav-1 siRNA significantly reduced basal and VEGF-stimulated phosphorylation of VEGFR2 (Y951), PLCgamma1 (Y783) and/or Akt (S473 & T308) relative to those in control siRNA treated cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP776637.RAKsLfRyTt9Xv-RkvKEEjqqinqupoYxalAki5IvFGC46g130_assertion description "[Downregulation of cav-1 in prostate cancer cell line PC-3 or human umbilical vein endothelial cells (HUVECs) through cav-1 siRNA significantly reduced basal and VEGF-stimulated phosphorylation of VEGFR2 (Y951), PLCgamma1 (Y783) and/or Akt (S473 & T308) relative to those in control siRNA treated cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP776637.RAKsLfRyTt9Xv-RkvKEEjqqinqupoYxalAki5IvFGC46g130_provenance.
• NP776638.RALo6KVPial9DAQ377Vb2HEY2G4Tv0RjOvW5kaUarKyZY130_assertion description "[Downregulation of cav-1 in prostate cancer cell line PC-3 or human umbilical vein endothelial cells (HUVECs) through cav-1 siRNA significantly reduced basal and VEGF-stimulated phosphorylation of VEGFR2 (Y951), PLCgamma1 (Y783) and/or Akt (S473 & T308) relative to those in control siRNA treated cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP776638.RALo6KVPial9DAQ377Vb2HEY2G4Tv0RjOvW5kaUarKyZY130_provenance.